ADC Therapeutics financial statements

Name: Quantus Signal — KR/US technical signal dataset
License: https://www.quantus.kr/signal/terms

ADC 테라퓨틱스NYSE:ADCT · New York Stock Exchange · Healthcare · sector #13

$1.23+8.85%

2026-10-05 close

ADC Therapeutics's published financial data is dated 2026-10-04. 2024 revenue was $71M. 2024 operating profit was −$131M.

Reported results

Quantus Signal · live data · not investment advice · Privacy Policy